Skip to main content
Log in

Immediate ART for HIV: long-term clinical benefits at modest cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ouattara EN, et al. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Cote d'Ivoire: A model-based analysis. PLOS One : 27 Jun 2019. Available from: URL: https://doi.org/10.1371/journal.pone.0219068

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Immediate ART for HIV: long-term clinical benefits at modest cost. PharmacoEcon Outcomes News 832, 16 (2019). https://doi.org/10.1007/s40274-019-6042-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6042-z

Navigation